Have a personal or library account? Click to login
Prevalence and Correlates of Ischemic ECG Findings among Adults With and Without HIV in Tanzania Cover

Prevalence and Correlates of Ischemic ECG Findings among Adults With and Without HIV in Tanzania

Global Heart
Volume 17 (2022): Issue 1
By: Sainikitha Prattipati,  Francis M. Sakita,  Tumsifu G. Tarimo,  Godfrey L. Kweka,  Jerome J. Mlangi,  Amedeus V. Maro,  Lauren A. Coaxum,  Sophie W. Galson,  Alexander T. Limkakeng,  Anzibert Rugakingira,  Sarah J. Urasa,  Nwora L. Okeke,  Blandina T. Mmbaga,  Gerald S. Bloomfield and  Julian T. Hertz  
Open Access
|Jun 2022

References

  1. 1Shah ASV, Stelzle D, Lee KK, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV. Circulation. 2018; 138(11): 1100–12. DOI: 10.1161/CIRCULATIONAHA.117.033369
    Back to article
  2. 2Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA. 2012; 308(4): 379–86. DOI: 10.1001/jama.2012.6698
    Back to article
  3. 3Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005; 352(1): 48–62. DOI: 10.1056/NEJMra041811
    Back to article
  4. 4Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr. 2010; 55(2): 262–70. DOI: 10.1097/QAI.0b013e3181e9be6b
    Back to article
  5. 5Croxford S, Kitching A, Desai S, et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: An analysis of a national observational cohort. Lancet Public Health. 2017; 2(1): e35–e46. DOI: 10.1016/S2468-2667(16)30020-2
    Back to article
  6. 6Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration. Lancet. 2014; 384(9939): 241–8. DOI: 10.1016/S0140-6736(14)60604-8
    Back to article
  7. 7Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018; 392(10159): 1736–88. DOI: 10.1016/S0140-6736(18)32203-7
    Back to article
  8. 8Hertz JT, Reardon JM, Rodrigues CG, et al. Acute myocardial infarction in sub-Saharan Africa: The need for data. PLoS One. 2014; 9(5): e96688. DOI: 10.1371/journal.pone.0096688
    Back to article
  9. 9Hyle EP, Mayosi BM, Middelkoop K, et al. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: A systematic review. BMC Public Health. 2017; 17(1): 954. DOI: 10.1186/s12889-017-4940-1
    Back to article
  10. 10Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J. 2012; 33(7): 866–74. DOI: 10.1093/eurheartj/ehr398
    Back to article
  11. 11Buggey J, Yun L, Hung CL, et al. HIV and pericardial fat are associated with abnormal cardiac structure and function among Ugandans. Heart. 2020; 106(2): 147–53. DOI: 10.1136/heartjnl-2019-315346
    Back to article
  12. 12Durand M, Sheehy O, Baril JG, Lelorier J, Tremblay CL. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: A cohort and nested case-control study using Quebec’s public health insurance database. J Acquir Immune Defic Syndr. 2011; 57(3): 245–53. DOI: 10.1097/QAI.0b013e31821d33a5
    Back to article
  13. 13Hertz JT, Kweka GL, Manavalan P, Watt MH, Sakita FM. Provider-perceived barriers to diagnosis and treatment of acute coronary syndrome in Tanzania: A qualitative study. Int Health. 2019; 12(2): 148–54. DOI: 10.1093/inthealth/ihz061
    Back to article
  14. 14Hertz JT, Kweka GL, Bloomfield GS, et al. Patterns of Emergency Care for Possible Acute Coronary Syndrome Among Patients with Chest Pain or Shortness of Breath at a Tanzanian Referral Hospital. Glob Heart. 2020; 15(1): 9. DOI: 10.5334/gh.402
    Back to article
  15. 15Hertz JT, Sakita FM, Kweka GL, et al. Acute myocardial infarction under-diagnosis and mortality in a Tanzanian emergency department: A prospective observational study. Am Heart J. 2020; 226: 214–21. DOI: 10.1016/j.ahj.2020.05.017
    Back to article
  16. 16Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Glob Heart. 2018; 13(4): 305–38. DOI: 10.1016/j.gheart.2018.08.004
    Back to article
  17. 17Ogunmodede JA, Kolo PM, Katibi IA, Salami AK, Omotoso A. Structural echocardiographic abnormalities seen in HIV/AIDS patients are independent of cd4 count. Niger J Clin Pract. 2017; 20(6): 716–23. DOI: 10.4103/1119-3077.208954
    Back to article
  18. 18Ogunmola OJ, Oladosu YO, Olamoyegun MA. QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs. Annals of African medicine. 2015; 14(4): 169–76. DOI: 10.4103/1596-3519.152072
    Back to article
  19. 19Hamadou B, Ngweth MN, Fotso MM, et al. Echocardiographic and electrocardiographic abnormalities in adults living with human immunodeficiency virus: A cross-sectional study in the Yaoundé Central Hospital, Cameroon. Cardiovasc Diagn Ther. 2017; 7(6): 607–15. DOI: 10.21037/cdt.2017.10.12
    Back to article
  20. 20Njoku PO, Ejim EC, Anisiuba BC, Ike SO, Onwubere BJ. Electrocardiographic findings in a cross-sectional study of human immunodeficiency virus (HIV) patients in Enugu, south-east Nigeria. Cardiovasc J Afr. 2016; 27(4): 252–7. DOI: 10.5830/CVJA-2016-007
    Back to article
  21. 21Roozen GVT, Meel R, Peper J, et al. Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa. PLoS One. 2021; 16(2): e0244742. DOI: 10.1371/journal.pone.0244742
    Back to article
  22. 22Kentoffio K, Albano A, Koplan B, et al. Electrocardiographic Evidence of Cardiac Disease by Sex and HIV Serostatus in Mbarara, Uganda. Global heart. 2019; 14(4): 395–7. DOI: 10.1016/j.gheart.2019.08.007
    Back to article
  23. 23Chastain DB, Veve MP, Wagner JL. Abnormal QTc syndrome in HIV-infected patients: a systematic review of prevalence and risk factors. Antivir Ther. 2019; 24(6): 459–65. DOI: 10.3851/IMP3335
    Back to article
  24. 24Myerson M, Kaplan-Lewis E, Poltavskiy E, Ferris D, Bang H. Prolonged QTc in HIV-Infected Patients: A Need for Routine ECG Screening. J Int Assoc Provid AIDS Care. 2019; 18: 2325958219833926. DOI: 10.1177/2325958219833926
    Back to article
  25. 25World Health Organization (WHO). WHO STEPS Instrument: The WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS). Geneva: World Health Organization; 2003.
    Back to article
  26. 26Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; The American College of Cardiology Foundation; And the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009; 53(11): 982–91. DOI: 10.1161/CIRCULATIONAHA.108.191096
    Back to article
  27. 27World Health Organization (WHO). Global Recommendations on Physical Activity for Health. Geneva: World Health Organization; 2011.
    Back to article
  28. 28Carr A, Grund B, Neuhaus J, et al. Asymptomatic myocardial ischaemia in HIV-infected adults. Aids. 2008; 22(2): 257–67. DOI: 10.1097/QAD.0b013e3282f20a77
    Back to article
  29. 29Bloomfield GS, Weir IR, Ribaudo HJ, et al. Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). J Acquir Immune Defic Syndr. 2022; 89(3): 349–59. DOI: 10.1097/QAI.0000000000002877
    Back to article
  30. 30Demir OM, Candilio L, Fuster D, et al. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol. 2018; 265: 195–203. DOI: 10.1016/j.ijcard.2018.03.137
    Back to article
  31. 31Negin J, Bärnighausen T, Lundgren JD, Mills EJ. Aging with HIV in Africa: The challenges of living longer. Aids. 2012; 26 Suppl 1(01): S1–5. DOI: 10.1097/QAD.0b013e3283560f54
    Back to article
  32. 32Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. Aids. 2010; 24(2): 243–53. DOI: 10.1097/QAD.0b013e328333ea9e
    Back to article
  33. 33Ssinabulya I, Kayima J, Longenecker C, et al. Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda. PLoS One. 2014; 9(2): e89537. DOI: 10.1371/journal.pone.0089537
    Back to article
  34. 34Post WS, Budoff M, Kingsley L, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014; 160(7): 458–67. DOI: 10.7326/M13-1754
    Back to article
  35. 35Knudsen AD, Kofoed KF, Gelpi M, et al. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV. AIDS. 2019; 33(14): 2205–10. DOI: 10.1097/QAD.0000000000002327
    Back to article
  36. 36Reinsch N, Arendt M, Geisel MH, et al. Prolongation of the QTc interval in HIV-infected individuals compared to the general population. Infection. 2017; 45(5): 659–67. DOI: 10.1007/s15010-017-1053-9
    Back to article
  37. 37Liu J, Shah SK, Basu-Ray I, Garcia-Diaz J, Khalid K, Saeed M. QT prolongation in HIV-positive patients: Review article. Indian Heart J. 2019; 71(6): 434–9. DOI: 10.1016/j.ihj.2019.11.259
    Back to article
  38. 38Colvin CJ. Strategies for engaging men in HIV services. Lancet HIV. 2019; 6(3): e191–e200. DOI: 10.1016/S2352-3018(19)30032-3
    Back to article
  39. 39Pirisi A. Low health literacy prevents equal access to care. Lancet. 2000; 356(9244): 1828. DOI: 10.1016/S0140-6736(05)73297-9
    Back to article
  40. 40Nadour W, Doyle M, Williams RB, et al. Does the presence of Q waves on the EKG accurately predict prior myocardial infarction when compared to cardiac magnetic resonance using late gadolinium enhancement? A cross-population study of noninfarct vs infarct patients. Heart Rhythm. 2014; 11(11): 2018–26. DOI: 10.1016/j.hrthm.2014.07.025
    Back to article
  41. 41Kaandorp TA, Bax JJ, Lamb HJ, et al. Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram? Am J Cardiol. 2005; 95(8): 925–9. DOI: 10.1016/j.amjcard.2004.12.028
    Back to article
  42. 42Godsk P, Jensen JS, Abildstrøm SZ, Appleyard M, Pedersen S, Mogelvang R. Prognostic significance of electrocardiographic Q-waves in a low-risk population. Europace. 2012; 14(7): 1012–7. DOI: 10.1093/europace/eur409
    Back to article
DOI: https://doi.org/10.5334/gh.1127 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Jan 19, 2022
Accepted on: May 18, 2022
Published on: Jun 10, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
ischemic ECG findings,
myocardial infarction,
HIV-infection,
sub-Saharan Africa

© 2022 Sainikitha Prattipati, Francis M. Sakita, Tumsifu G. Tarimo, Godfrey L. Kweka, Jerome J. Mlangi, Amedeus V. Maro, Lauren A. Coaxum, Sophie W. Galson, Alexander T. Limkakeng, Anzibert Rugakingira, Sarah J. Urasa, Nwora L. Okeke, Blandina T. Mmbaga, Gerald S. Bloomfield, Julian T. Hertz, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 17 (2022): Issue 1Next article